CPHA Canvax

The primary objective of this Interim Guidance is to review evidence on the safety and immunogenicity of PNEU-C-15 in the pediatric age group and to develop interim recommendations on its interchangeability with PNEU-C-13 for use in routine pediatric schedules as well as for children at high risk of IPD.

Rating See Comments Ratings


Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Vaccine Preventable Diseases,Communicable Diseases,Pneumococcal Disease,Specific Populations,Children Program Planning and Delivery
Program Delivery and Evaluation
Vaccine Preventable Diseases
Communicable Diseases
Pneumococcal Disease
Specific Populations


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.